| Dr Barbara Witlin Guggenheim, PHD | |
|
11726 San Vicente Blvd Ste 680, Los Angeles, CA 90049-5049 | |
| (310) 820-8655 | |
| (310) 471-3346 |
| Full Name | Dr Barbara Witlin Guggenheim |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 11726 San Vicente Blvd Ste 680, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104032077 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY4479 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barbara Witlin Guggenheim, PHD 11726 San Vicente Blvd Ste 680, Los Angeles, CA 90049-5049 Ph: (310) 820-8655 | Dr Barbara Witlin Guggenheim, PHD 11726 San Vicente Blvd Ste 680, Los Angeles, CA 90049-5049 Ph: (310) 820-8655 |
News Archive
Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.
Mylan Inc. today announced that it plans to change the name of its fully integrated branded specialty pharmaceutical business from Dey Pharma to Mylan Specialty.
Genentech, Inc., a wholly owned member of the Roche Group, announced today the topline results of a Phase III trial led by the U.S. Cancer and Leukemia Group B (CALGB) and sponsored by the National Cancer Institute investigating the use of Avastin® (bevacizumab) in combination with docetaxel chemotherapy and prednisone in men with late stage prostate cancer (hormone-refractory / HRPC).
Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application from the US Food and Drug Administration for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.
› Verified 6 days ago
Dr. Jennie M. Mathess, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 840 N Avenue 66, Los Angeles, CA 90042 Phone: 626-395-7100 | |
Dr. Dennis S. Klos, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1554 S Sepulveda Blvd, Suite 211, Los Angeles, CA 90025 Phone: 310-476-5277 | |
Dr. Karen Siscoe, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 450 Bauchet St, Los Angeles, CA 90012 Phone: 213-473-6530 | |
Dr. Kara Taguchi, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 550 S Vermont Ave, Adult Systems Of Care, 12th Floor, Los Angeles, CA 90020 Phone: 213-305-2999 Fax: 213-381-5497 | |
Dr. Kara Lynn Hart, PSY,D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11500 W Olympic Blvd, Suite 500, Los Angeles, CA 90064 Phone: 310-871-7825 Fax: 310-478-6698 | |
Molly Cevasco, PH.D., BCBA Psychologist Medicare: Medicare Enrolled Practice Location: 4650 W Sunset Blvd, Ms #53, Los Angeles, CA 90027 Phone: 323-361-3849 | |
Dr. Adam Vogel, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 621 S Virgil Ave, #300, Los Angeles, CA 90005 Phone: 213-368-5400 |